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Introduction
Androgens are hormones that are based on the structure 
of testosterone and act on various tissues via androgen 
receptors to produce anabolic effects (i.e., Increasing protein 
synthesis), as well as androgenic effects, (i.e., Development 
of secondary sexual characteristics).[1,2] In addition, they 
displace glucocorticoids from their respective receptors, 
exerting an anti-catabolic effect, which also promotes protein 
synthesis.[2,3] Androgen receptors are found in bone, adipose 
tissue, skeletal muscle, brain, prostate, liver, kidney, and 
reproductive tissues, which accounts for both their desired 
and adverse effects.[2] Anabolic-androgenic steroids (AAS) do 
possess medical indication, primarily in androgen replacement 
therapies	for	patients	with	established	androgen	deficiencies;[1] 
however, AAS are frequently abused by individuals interested 
in capitalizing on their effects.
Anabolic-androgenic steroids use and abuse are important 
concerns for the medical community, as their utilization 
has been steadily increasing over the past four decades, 
with a global lifetime prevalence rate for AAS use of 3.3%; 
use	 by	males	 (6.4%)	was	 significantly	 higher	 than	 that	 by	
females (1.6%).[3,4] Professional athletes are a population 
classically associated with AAS utilization due to the potential 
for an increase in muscle strength,[1,3,5] as well as fat-free muscle 
mass.[3]	However,	 these	benefits	do	not	come	without	risks.	
Some reported adverse effects included virilization in female 
users, truncal acne, weight gain, gynecomastia, polycythemia, 
congestive cardiac failure and myocardial infarctions, 
dyslipidemia, mood alteration, and renal failure.[1,2,6-9] In 
addition, the abuse of AAS has expanded beyond the scope of 
professional athletes to include high school students (1–5%), 
individuals (i.e., recreational body builders), focused on 
physique (13.5%), as well as certain occupations (i.e., police 
officers).[3,10]
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Abstract
Intussusceptions are generally associated with mechanical lead points or localized inflammation 
that function as foci for intestinal telescoping. We present the case of a patient whose abuse 
of anabolic steroids resulted in the development of multiple simultaneous intussusceptions. 
Our patient had no additional identifiable risk factors for intussusception. Consistent with 
previous reports, corticosteroid induced polycythemia and its consequent hyperviscosity led 
to intravascular sludging and mesenteric ischemia with associated bowel wall thickening. 
The localized intestinal induration then served as mechanical foci for intussusception. Due 
to the illicit nature of anabolic androgenic steroid (AAS) abuse, the physiologic effects of 
supraphysiologic doses are sparsely reported and poorly understood. The scope of AAS abuse 
and its consequences are likely under‑reported and under‑recognized within the medical 
community. Our case presented a unique diagnostic and therapeutic challenge with which 
we aim to increasing awareness and clinical suspicion for AAS among healthcare personnel.
Keywords: Anabolic, Steroid, Intussusception, Androgens, Polycythemia, Hormones, 
Anabolic androgenic steroid
Access this article online
Quick Response Code:
Website: www.amhsr.org
DOI:  
*****
Case Report
Cavanagh, et al.: Multiple intussusceptions in an anabolic steroid abuser
Annals of Medical and Health Sciences Research | Sep-Oct 2015 | Vol 5 | Issue 5 | 369
Due to the predominantly illicit nature of AAS abuse, 
studying side effects and complications of supraphysiologic 
doses	 is	 inherently	 difficult.	Most	 clinical	 studies	 evaluate	
low-dose AAS for the purposes of hormone replacement, 
either	due	to	androgen	deficiency	in	hypogonadal	syndromes,	
cachexia	(i.e.,	conditions	such	as	human	immunodeficiency	
virus, chronic obstructive pulmonary disease) or age-related 
declines (i.e., testosterone deficiency), although the last 
area remains controversial.[6,7,11-13] Normal daily endogenous 
production of cortisol would equate to about 10–50 mg of 
exogenously administered cortisol. Men require higher doses 
for physiologic homeostasis.[14,15] However, there are no 
specific	guidelines	on	the	appropriate	dosing	of	AAS	to	mimic	
or supplement, normal physiologic hormone levels.
Bhasin et al.[5] has conducted one of the few randomized studies 
to look at the effects of supraphysiologic doses of AAS. In 
their trial, patients received weekly intramuscular doses of 
600 mg of testosterone enanthate or placebo for 10 weeks.[5] 
However, the doses utilized were still substantially lower than 
those commonly utilized by athletes, who additionally tend to 
stack multiple AAS preparations in an attempt to increase the 
desired effects while decreasing potential adverse effects.[2,16] 
Therefore, case reports and retrospective studies have been 
the principal contributors in identifying common, as well as 
life-threatening, complications, which may potentially arise 
from AAS abuse.[2,3,17]
Case Report
We present the case of a 34-year-old male with a past medical 
history	of	hypertension,	hypercholesteremia,	anxiety,	acid	reflux,	
and irritable bowel syndrome who presented with the complaints 
of severe cramping abdominal pain associated with nausea, 
vomiting, bright red blood per rectum, and constipation. The 
patient denied having similar symptoms in the past or any history 
of abdominal surgery. He had an upper gastrointestinal series 
10 years ago, which was unremarkable except for a hiatal hernia. 
He is a body builder and admitted to the use of AAS. He was 
1500 mg of testosterone/nandrolone, via intramuscular injection, 
per week for 3 months. 3 weeks prior to the presentation, he 
abruptly decreased the dose to 500 mg/week.
On presentation, he was found to be diaphoretic, in mild 
distress, with tachycardia at 100 beats/min and tenderness in 
the suprapubic region with no guarding, rebound tenderness 
or palpable masses. Laboratory studies were normal apart 
from an increased white blood cell count at 15.0, increased 
hemoglobin at 17.9 and increased hematocrit at 51.2%. He 
had mild changes in sodium (134), as well as blood urea 
nitrogen (24). He weighed 265 pounds, with a body mass index 
of 40.3. A computer tomography (CT) scan of the abdomen 
demonstrated	mild	diffuse	nonspecific	colonic	wall	thickening,	
with two separate areas of apparent short segment small bowel 
intussusception without evidence of obstruction [Figures 1-4]. 
Figure 1: Transverse plane computer tomography scan of the abdomen 
demonstrating a short segment small bowel intussusception without 
evidence of obstruction
Figure 3: Sagittal plane computer tomography scan of the abdomen 
demonstrating a short segment small bowel intussusceptions without 
evidence of obstruction
Figure 2: Sagittal plane computer tomography scan of the abdomen 
demonstrating a short segment small bowel intussusception without 
evidence of obstruction
Cavanagh, et al.: Multiple intussusceptions in an anabolic steroid abuser
370 Annals of Medical and Health Sciences Research | Sep-Oct 2015 | Vol 5 | Issue 5 |
In addition, a small umbilical hernia containing fat was 
visualized. Our patient was subsequently medically managed, 
with pain control and hydration. A colonoscopy completed 
the day after admission demonstrated edema and erythema 
in the distal ileum and colon, most densely starting in the 
distal transverse colon and increasing within the rectum. 
There were no ulcers, polyps, tumors or sites of hemorrhage 
noted. Biopsies were taken from each section of the colon. 
The subsequent pathological evaluation indicated acute and 
chronic colitis from the descending colon forward and changes 
suggesting ischemic colitis in the rectum [Figures 5-7].
A follow-up CT scan was completed on the third day of admission 
but	 demonstrated	no	definitive	 intussusceptions	 [Figure 8]. 
There was no longer any overt colitis evidenced though 
there	may	 have	 been	 an	 underlying	 inflammatory	 process	
based on submucosal lucency in the transverse colon. With 
the apparent resolution of the small bowel intussusceptions 
with conservative medical management, accompanied by a 
resolution of the patient’s pain, he was discharged home.
Discussion
Among other potentially dangerous adverse effects, AAS have 
been reported to increase hemoglobin concentrations.[1,7,8,17,18] 
This is consistent with our observation, where our patient 
was	 an	 active	AAS	 user	 and	 presented	with	 a	 significant	
increase in hemoglobin concentration. It is of note that 
older men (ages 60–74) are at a greater risk of developing 
hematocrits above 54%.[6] Coviello et al. [7] investigated the 
biochemistry that leads to this effect and have ruled out 
increases in erythropoietin levels, as well as expression 
of soluble transferrin receptor, the erythropoietin receptor 
in the bone marrow[7] as the causative mechanisms.[7] The 
current hypothesis is that AAS act by directly stimulating 
the bone marrow via a mechanism not yet determined.[7,19] 
Interestingly, Verwilghen et al.[8] even suggested that, based 
on measurements of peripheral blood, polycythemia seen in 
the setting of AAS abuse may be due to a decrease in plasma 
volume, demonstrating a compounding relative increase in 
hemoglobin concentration.
Figure 4: Transverse plane computer tomography scan of the abdomen 
demonstrating a short segment small bowel intussusceptions without 
evidence of obstruction, and a small umbilical hernia containing fat
Figure 5: H and E, slide at ×400 magnification showing a few 
aggregates of foamy macrophages, superficial erosion, congestion, 
and dilatation of lamina propria capillaries, as well as withered crypts
Figure 6: H and E slide at ×400 magnification showing acute and 
chronic inflammatory infiltrates
Figure 7: H and E slide at ×400 magnification showing fresh intestinal 
hemorrhage
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Polycythemia inherently places patients at an increased risk 
for ischemic events.[B, D, G] Stergiopoulos et al.[17]  described 
an increase in ischemic cardiac events secondary to the 
polycythemia associated with AAS use.[7,17] McCulloch et al.[9] 
reported the case of a patient abusing AAS, who presented 
with multiple arterial thromboses, including the splenic and 
right renal arteries, reporting that the ischemic effects of 
steroids can affect larger vessels.[9] Similarly to our case, 
Magnusson et al.[20] published a case of polycythemia vera 
and associated small bowel obstruction, where laparotomy 
demonstrated transmural ischemia in the distal sigmoid 
colon and proximal rectum. Plackett et al.[19] also presented 
a case of colonic ischemia, with resulting thickening of the 
bowel walls that, they also postulated, acted as a lead point 
for an intussusception. However, unlike our patient, their 
patient presented with colonic ischemia secondary to portal 
hypertension. Similarly to our patient, was medically managed 
with supportive measures and demonstrated resolution of the 
intussusceptions on a repeated CT scan.[19]
Intussusception, although common in children, is a rare 
clinical	 finding	 in	 adults.	Adults	 account	 for	 only	 5%	 of	
all cases of intussusceptions, which are the cause of 1–5% 
of all intestinal obstructions in adults.[19,21,22] In adults, it is 
generally associated with an underlying mechanical lead 
point that serves as a focus for the intussusception (such as 
a benign polyp, lipoma, appendix, Meckel diverticulum or 
a tumor [i.e., lymphoma]).[23] Additional sources of lead 
points	can	include	inflammatory	pseudopolyps,	arteriovenous	
malformations	or	localized	inflammation	(due	to	tuberculosis,	
cytomegalovirus, campylobacter, and Crohn’s disease).[19,21-23]
In the case we are presenting, the patient did not display 
any of these typical risk factors for his development of an 
intussusception. He had no personal or family history of 
polyposis, no intestinal malignancy or isolated infectious 
process.	The	only	identified	potential	causative	factor	was	the	
patient’s chronic use of AAS. Our case suggests, consistently 
with previous reports that, the patient’s use of AAS led to 
the development of polycythemia.[2,7,9,17,19,24] The consequent 
hyperviscosity likely leads to intravascular sludging and 
subsequent mesenteric ischemia with associated bowel wall 
thickening that subsequently served as a lead points in the 
formation of two short segment small bowel intussusceptions.
In general, surgical reduction is the preferred treatment 
in adults with intussusception.[21,22] This is due to the fact 
that intussusception is most commonly associated with a 
pathological lesion that leads to a telescoping of the intestine 
upon itself by virtue of creating a lead point.[19,21-23] However, in 
our case, as well as that of Plackett et al., the patient’s conditions 
resolved with hydration.[19] It remains uncertain whether 
decreased plasma volume or a directly mediated stimulation 
of the bone marrow are responsible for the hyperviscosity, 
which is associated with AAS abuse.[1,6-8,17] However, in cases 
of intussusception secondary to AAS abuse, the physiological 
process appears to be amenable to treatment with hydration, 
which decreases the degree of hemoconcentration. This could 
subsequently spare patients the need for surgical interventions. 
In our case, as the patient presented with intussusceptions 
without evidence of obstruction, medical management was 
justifiably	and	successfully	implemented,	even	in	the	setting	
of multiple intussusceptions. As such, we propose that a trial of 
medical management may be indicated; even in those patients 
presenting with mild obstruction secondary to AAS induced 
ischemia, due to its unique pathology.
The physiologic process by which AAS induce ischemic events 
remains	 unclear	 and	 certainly	 postulates	 a	 field	 of	 further	
exploration, for follow-up studies. Currently, polycythemia and 
decreased plasma volume appear to mediate hyperviscosity, 
causing mechanical vascular obstruction. However, it has 
been reported that, androgens potentiate platelet aggregation 
via either an increased production of thromboxane A2 or a 
decrease in prostaglandin production.[9,24,25] This procoagulant 
state further places AAS users at an increased risk for ischemic 
events by compounding the hyperviscosity potentiated by 
increased hemoglobin concentrations. This direct procoagulant 
pathway activation, as suggested by McCulloch, Pilo, and 
Johnson et al.’s investigations, as well as other alterations 
of the pro and anticoagulant systems, including entities such 
as AAS induced vasospasm require further investigation as 
contributing factors.[9,24,25]
Our case presented a unique diagnostic, as well as therapeutic 
challenge since its presentation as a complication of AAS 
abuse, has not been overtly reported in previous literature. 
However,	as	our	patient	had	no	 identifiable	 risk	 factors	 for	
the development of intussusception, the only potential cause 
was ischemic colitis secondary to polycythemia, attributable 
to our patient’s supraphysiologic AAS use. As it is ethically 
dubious to perform clinical trials with supraphysiologic doses 
of AAS frequently used by people aiming to capitalize on the 
anabolic effects, this case aims to illustrate an additional end 
Figure 8: Resolution of small bowel intussusceptions with no evidence 
of overt colitis
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point complication that can occur secondary to AAS abuse. 
Although, we cannot comment on the incidence of similar 
complications, clinical awareness, and increased suspicion will 
undoubtedly increase the diagnostic margin of this process. As 
such, it is important for clinicians to consider intussusception, 
as well as other ischemic complications, when treating patients 
with a history of AAS abuse.
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